DekaBank Deutsche Girozentrale Has $2.44 Million Position in Celsius Holdings, Inc. (NASDAQ:CELH)

DekaBank Deutsche Girozentrale grew its position in Celsius Holdings, Inc. (NASDAQ:CELH) by 95.5% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 77,696 shares of the company’s stock after buying an additional 37,962 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in Celsius were worth $2,437,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. raised its position in shares of Celsius by 18.7% in the 1st quarter. Vanguard Group Inc. now owns 16,313,762 shares of the company’s stock valued at $1,352,737,000 after buying an additional 2,567,290 shares in the last quarter. Capital International Investors increased its position in Celsius by 50.6% during the 1st quarter. Capital International Investors now owns 3,966,194 shares of the company’s stock worth $328,877,000 after purchasing an additional 1,333,217 shares in the last quarter. Massachusetts Financial Services Co. MA increased its position in Celsius by 231.2% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 3,946,208 shares of the company’s stock worth $225,289,000 after purchasing an additional 2,754,722 shares in the last quarter. Bank of New York Mellon Corp increased its position in Celsius by 36.7% during the 2nd quarter. Bank of New York Mellon Corp now owns 2,942,433 shares of the company’s stock worth $167,983,000 after purchasing an additional 790,014 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD increased its position in Celsius by 0.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,802,264 shares of the company’s stock worth $232,365,000 after purchasing an additional 9,054 shares in the last quarter. 60.95% of the stock is currently owned by institutional investors and hedge funds.

Celsius Stock Performance

NASDAQ:CELH opened at $31.48 on Friday. The firm’s fifty day moving average is $32.99 and its 200-day moving average is $52.60. Celsius Holdings, Inc. has a 52 week low of $28.20 and a 52 week high of $99.62. The firm has a market cap of $7.34 billion, a P/E ratio of 30.86, a P/E/G ratio of 2.38 and a beta of 1.84.

Celsius (NASDAQ:CELH) last issued its earnings results on Tuesday, August 6th. The company reported $0.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.05. The business had revenue of $402.00 million for the quarter, compared to analyst estimates of $391.07 million. Celsius had a net margin of 19.58% and a return on equity of 94.75%. Celsius’s revenue was up 23.4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.17 earnings per share. As a group, sell-side analysts anticipate that Celsius Holdings, Inc. will post 0.79 earnings per share for the current year.

Insider Buying and Selling

In related news, CEO John Fieldly sold 74,847 shares of the stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $32.80, for a total transaction of $2,454,981.60. Following the transaction, the chief executive officer now directly owns 1,812,490 shares of the company’s stock, valued at $59,449,672. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.20% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

CELH has been the subject of a number of research analyst reports. B. Riley lowered their price objective on shares of Celsius from $80.00 to $73.00 and set a “buy” rating for the company in a research report on Wednesday, August 7th. Stifel Nicolaus lowered their price objective on shares of Celsius from $61.00 to $51.00 and set a “buy” rating for the company in a research report on Thursday, September 5th. Truist Financial boosted their target price on shares of Celsius from $30.00 to $35.00 and gave the stock a “hold” rating in a report on Wednesday, October 16th. UBS Group reduced their target price on shares of Celsius from $70.00 to $64.00 and set a “buy” rating on the stock in a report on Wednesday, August 7th. Finally, Roth Mkm reduced their target price on shares of Celsius from $45.00 to $43.00 and set a “buy” rating on the stock in a report on Friday, September 27th. One analyst has rated the stock with a sell rating, three have issued a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat.com, Celsius presently has an average rating of “Moderate Buy” and a consensus target price of $58.00.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.